China’s Public Hospitals To Dance As Private Insurance Gains Traction?
This article was originally published in PharmAsia News
China’s health insurance sector, currently accounting for just 3% of the total insurance market, is slowly gaining momentum. Growth catalysts are rapidly emerging, given that as the country transforms itself into a value-added economy, public hospitals are coming under mounting pressure to control costs and improve quality, both areas in which commercial insurers have a strong role to play, experts say.
You may also be interested in...
Throughout 2020, China’s drive to introduce more and newer drugs to the market did not slow but was rather accelerated by the COVID-19 pandemic. But can people afford them?
From bringing innovative new drugs to global markets, to record-setting fundraisings and initial public offerings, five trends are emerging in China's health sector that are worth closely watching in 2021.
One year after the first cases of a novel coronavirus emerged in Wuhan, a team from the World Health Organization has arrived in the city to investigate its origin. Meanwhile, mixed results are reported for some of the leading Chinese vaccines being developed to fight the pandemic still wreaking global havoc.